Holen Sie sich die Stockscreener-App
3.65
0.00%
0.00
Vorhandelsmarkt:
3.54
-0.11
-3.01%
Schlusskurs vom Vortag:
$3.65
Offen:
$3.56
24-Stunden-Volumen:
2.56M
Relative Volume:
2.36
Marktkapitalisierung:
$862.26M
Einnahmen:
$4.90M
Nettoeinkommen (Verlust:
$-399.99M
KGV:
-1.2849
EPS:
-2.8407
Netto-Cashflow:
$-122.90M
1W Leistung:
-5.44%
1M Leistung:
-22.01%
6M Leistung:
-36.85%
1J Leistung:
-39.37%
1-Tages-Spanne:
$3.48
$3.675
1-Wochen-Bereich:
$3.48
$3.945
52-Wochen-Spanne:
$3.35
$7.9825
Inventiva Adr Stock (IVA) Company Profile
Compare IVA vs VRTX, REGN, MRNA, ARGX, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IVA
Inventiva Adr
|
3.65 | 949.66M | 4.90M | -399.99M | -122.90M | -2.8407 |
VRTX
Vertex Pharmaceuticals Inc
|
514.99 | 130.64B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
803.90 | 80.46B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
182.56 | 57.48B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
963.79 | 61.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ONC
Beone Medicines Ltd Adr
|
368.08 | 39.20B | 5.76B | 514.49M | 1.10B | 4.4813 |
Inventiva Adr Stock (IVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-19 | Eingeleitet | Truist | Buy |
| 2026-01-28 | Eingeleitet | Barclays | Overweight |
| 2026-01-12 | Eingeleitet | Leerink Partners | Outperform |
| 2026-01-07 | Fortgesetzt | UBS | Buy |
| 2025-11-06 | Eingeleitet | Wolfe Research | Outperform |
| 2025-09-03 | Fortgesetzt | H.C. Wainwright | Buy |
| 2025-08-27 | Eingeleitet | Piper Sandler | Overweight |
| 2025-02-21 | Eingeleitet | TD Cowen | Buy |
| 2024-11-12 | Eingeleitet | UBS | Neutral |
| 2023-10-27 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-05-31 | Eingeleitet | ROTH MKM | Buy |
| 2023-05-19 | Hochstufung | Societe Generale | Sell → Buy |
| 2023-03-17 | Eingeleitet | Stifel | Buy |
| 2022-11-15 | Herabstufung | Societe Generale | Buy → Sell |
| 2021-03-08 | Herabstufung | Societe Generale | Buy → Sell |
| 2020-08-05 | Eingeleitet | ROTH Capital | Buy |
| 2020-08-04 | Eingeleitet | Guggenheim | Buy |
| 2020-08-04 | Eingeleitet | Stifel | Buy |
Alle ansehen
Inventiva Adr Aktie (IVA) Neueste Nachrichten
IVA - Finviz
CapEx per share of Inventiva SA ADR – HAM:6IVA - TradingView
6IVA Stock Price and Chart — HAM:6IVA - TradingView
IVA News | INVENTIVA SAADR (NASDAQ:IVA) - ChartMill
IVA Price History for Inventiva S.A. ADR Stock - Barchart.com
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Given Average Rating of "Buy" by Brokerages - MarketBeat
Inventiva S.A. Sponsored ADR $IVA Stake Reduced by Ally Bridge Group NY LLC - MarketBeat
Inventiva (IVA) Short Interest & Short Float | Updated Jul 2026 $IVA - MarketBeat
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
Cantor Fitzgerald Initiates Inventiva SA ADR at Overweight - Moomoo
Inventiva (IVA) Announces Issuance of New EIB Warrants, Completes EIB Warrant Restructuring - Yahoo Finance
After plunging 30.8% in 4 weeks, here's why the trend might reverse for Inventiva (IVA) - MSN
Down 31.8% in 4 weeks, here's why Inventiva (IVA) looks ripe for a turnaround - MSN
6IVA Forecast — Price Target — Prediction for 2027 - TradingView
Inventiva S.A. (IVA) is One of the Best Stocks Under $10 Offering More Than 50% Upside - Yahoo Finance
After Plunging 30.8% in 4 Weeks, Here's Why the Trend Might Reverse for Inventiva (IVA) - Yahoo Finance
A2P796 Forecast — Price Target — Prediction for 2027 - TradingView
Inventiva SA ADR Actuals & Estimates (LSX:A2P796) - TradingView
Inventiva SA ADR Actuals & Estimates (LS:A2P796) - TradingView
Inventiva SA ADR Actuals & Estimates (NASDAQ:IVA) - TradingView
Claret Capital Partners participates in €130m financing for Inventiva to support Phase 3 development - GlobeNewswire Inc.
Down 31.8% in 4 Weeks, Here's Why Inventiva (IVA) Looks Ripe for a Turnaround - Yahoo Finance
Super Micro Computer, Summit Therapeutics And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session - Sahm
IVA SEC FilingsInventiva S.A. 10-K, 10-Q, 8-K Forms - Stock Titan
Here's Why Inventiva (IVA) Is a Great 'Buy the Bottom' Stock Now - MSN
Assessing Inventiva (ENXTPA:IVA) Valuation As Losses Deepen And MASH Trial Progresses - Yahoo Finance
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Given Consensus Recommendation of "Buy" by Brokerages - MarketBeat
Phreesia, Service Properties Trust, Inventiva and other big stocks moving lower in Tuesday's pre-market session - MSN
Inventiva (NASDAQ:IVA) Sees Large Volume IncreaseHere's What Happened - MarketBeat
Phreesia, Service Properties Trust, Inventiva And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Short Interest Update - MarketBeat
Zenas Biopharma, Daqo New Energy and other big stocks moving lower in Friday's pre-market session - MSN
Zenas Biopharma, Daqo New Energy And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
Does Inventiva (IVA) have the potential to rally 136.34% as Wall Street analysts expect? - MSN
Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Receives $17.00 Consensus PT from Brokerages - Defense World
Short Interest in Inventiva S.A. Sponsored ADR (NASDAQ:IVA) Drops By 20.4% - MarketBeat
Does Inventiva (IVA) Have the Potential to Rally 136.34% as Wall Street Analysts Expect? - Yahoo Finance
Inventiva CEO: Phase 3 Lanifibranor MASH Trial Fully Enrolled, Top-Line Data Due in H2 - Yahoo Finance
Are You Looking for a Top Momentum Pick? Why Inventiva S.A. Sponsored ADR (IVA) is a Great Choice - Yahoo Finance
Inventiva SA ADR Trade Ideas — LSX:A2P796 - TradingView
Wall Street Analysts Predict a 200.59% Upside in Inventiva (IVA): Here's What You Should Know - Yahoo Finance
Why Heartbeam Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket - Benzinga
Finanzdaten der Inventiva Adr-Aktie (IVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.14%
0.15%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):